UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"

International journal of health policy and management, 2020-06, Vol.9 (6), p.260-262

Drummond, Michael F

2020

Volltextzugriff (PDF)

European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies

Journal of clinical oncology, 2007-01, Vol.25 (2), p.191-195

2007

Volltextzugriff (PDF)

Real-world evidence for coverage determination of treatments for rare diseases

Orphanet journal of rare diseases, 2024-02, Vol.19 (1), p.47-47, Article 47

2024

Volltextzugriff (PDF)

Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis

BMJ open, 2020-02, Vol.10 (2), p.e034463-e034463

2020

Volltextzugriff (PDF)

The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

Value in health, 2012-12, Vol.15 (8), p.1148-1161

2012

Volltextzugriff (PDF)

Taking Steps Toward Transparency in Real-World Evidence Studies

Value in health, 2020-09, Vol.23 (9), p.1119-1119

Drummond, Michael F.

2020

Volltextzugriff (PDF)

The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom

Vaccines (Basel), 2021-06, Vol.9 (6), p.598

2021

Volltextzugriff (PDF)

An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom

Vaccines (Basel), 2022-04, Vol.10 (4), p.599

2022

Volltextzugriff (PDF)

Colonoscopy vs the Fecal Immunochemical Test: Which is Best?

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.758-771

2024

Volltextzugriff (PDF)

Data Privacy and Health: How Do We Achieve the Right Balance?

Value in health, 2023-09, Vol.26 (9), p.1283-1285

2023

Volltextzugriff (PDF)

Twenty-Five Years of Health Economics and Outcomes Research: An Exploration of Value in Health

Value in health, 2023-05, Vol.26 (5), p.617-619

2023

Volltextzugriff (PDF)

Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis

Value in health, 2020-01, Vol.23 (1), p.17-24

2020

Volltextzugriff (PDF)

Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues

Value in health, 2024-06, Vol.27 (6), p.689-691

2024

Volltextzugriff (PDF)

Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]

Value in health, 2018-02, Vol.21 (2), p.146-154

2018

Volltextzugriff (PDF)

Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report [4]

Value in health, 2018-02, Vol.21 (2), p.140-145

2018

Volltextzugriff (PDF)

Transparency, openness, and reproducible research practices are frequently underused in health economic evaluations

Journal of clinical epidemiology, 2024-01, Vol.165, p.111208-111208, Article 111208

2024

Volltextzugriff (PDF)

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

Value in health, 2019-06, Vol.22 (6), p.661-668

2019

Volltextzugriff (PDF)

A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

Value in health, 2018-02, Vol.21 (2), p.161-165

2018

Volltextzugriff (PDF)

The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)

Value in health, 2020-11, Vol.23 (11), p.1403-1404

2020

Volltextzugriff (PDF)

Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective

Value in health, 2021-11, Vol.24 (11), p.1686-1699

2021

Volltextzugriff (PDF)

A Value Framework for the Assessment of Diagnostic Technologies: A Proposal Based on a Targeted Systematic Review and a Multistakeholder Deliberative Process in Latin America

Value in health, 2021-04, Vol.24 (4), p.486-496

2021

Volltextzugriff (PDF)

Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America

Value in health, 2019-06, Vol.22 (6), p.739-749

2019

Volltextzugriff (PDF)

Yes, Authorship Is Important

Value in health, 2020-07, Vol.23 (7), p.827-828

2020

Volltextzugriff (PDF)

Improving the Quality of Papers Published in Pharmacoeconomics and Outcomes Research

Value in health, 2013-03, Vol.16 (2), p.229-230

2013

Volltextzugriff (PDF)

An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations

Expert review of medical devices, 2023-04, Vol.20 (4), p.259-271

2023

Volltextzugriff (PDF)

1 – 25 von 350

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(243)
Life Sciences & Biomedicine
(211)
Humans
(168)
Health Care Sciences & Services
(85)
Health Policy & Services
(63)
Economics
(56)
Biological And Medical Sciences
(54)
Social Sciences
(54)
Business & Economics
(50)
Male
(50)
Female
(49)
Cost-Benefit Analysis
(48)
Medical Sciences
(48)
Health Economics
(36)
Decision Making
(35)
Animals
(34)
Cost Analysis
(34)
Health Technology Assessment
(33)
Adult
(31)
Public, Environmental & Occupational Health
(28)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"

European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies

Real-world evidence for coverage determination of treatments for rare diseases

Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis

The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

Taking Steps Toward Transparency in Real-World Evidence Studies

The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom

An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom

Colonoscopy vs the Fecal Immunochemical Test: Which is Best?

Data Privacy and Health: How Do We Achieve the Right Balance?

Twenty-Five Years of Health Economics and Outcomes Research: An Exploration of Value in Health

Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis

Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues

Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]

Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report [4]

Transparency, openness, and reproducible research practices are frequently underused in health economic evaluations

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)

Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective

A Value Framework for the Assessment of Diagnostic Technologies: A Proposal Based on a Targeted Systematic Review and a Multistakeholder Deliberative Process in Latin America

Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America

Yes, Authorship Is Important

Improving the Quality of Papers Published in Pharmacoeconomics and Outcomes Research

An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations

Suchergebnisse filtern